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Abstract
Background:  The registration of non-fatal and fatal MI events initiated 1985 in the WHO
MONICA project has been ongoing in northern Sweden since the end of the WHO project in
1995. The purpose of the present study was to analyze gender differences in first and recurrent
events, case fatality and mortality in myocardial infarction (MI) in Northern Sweden during the 20-
year period 1985 – 2004.
Methods: Diagnosed MI events in subjects aged 25–64 years in the Counties of Norrbotten and
Västerbotten were validated according to the MONICA protocol. The total number of events
registered up to January 1, 2005 was 11,763: 9,387 in men and 2,376 in women.
Results: The proportion of male/female events has decreased from 5.5:1 to 3:1. For males the
reductions were 30% and 70% for first and recurrent MI, respectively, and for women 0% and 40%
in the 55–64 year group. For both sexes a 50% reduction in 28-day case fatality was seen in the 25–
64 year-group. Mortality was reduced by 69% and 45% in men and women, respectively.
Conclusion: First and recurrent events of myocardial infarction was markedly reduced in men
over the 20-year observation period, but for women the reduction was seen only for recurrent
infarctions. Case fatality, on the other hand, was markedly reduced for both sexes. As a result of
the positive effects on incidence and case fatality a substantial reduction was seen in total mortality,
most pronounced for men.
Background
Coronary heart disease (CHD) is the leading cause of
death in Sweden as well as in most Western European
countries and in the United States. Incidence and mortal-
ity rates in CHD have decreased substantially during the
last decades, and this trend seems to continue [1-4].
At the start of the MONICA project in 1985 the incidence
of, and mortality due to, myocardial infarction (MI) in the
two northernmost counties in Sweden were the highest in
the country. However, they have gradually approached
the national average indicating a faster reduction in
Northern Sweden than in the rest of the country [5]. Gen-
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erally, in the Western world, the decreased mortality in
CHD is due to a combination of declining incidence and
improved survival. Better primary prevention and
improvements in acute coronary care, including second-
ary prevention, may explain these impressing achieve-
ments [1].
Gender differences in both events and case-fatality, and
thereby also in mortality due to CHD, have been shown
in previous publications from northern Sweden and else-
where. The downward trends in first acute MI, recurrent
MI, case fatality and mortality have been particularly
strong in men, whereas the declines in women have been
less impressive [6-8].
The reasons behind the differing time trends after MI
between the sexes have been much debated. Suggested
explanations have included: problems for women to get a
correct diagnosis due to more atypical clinical presenta-
tion and a resulting longer delay between onset and med-
ical presence, later onset of the disease in life and less
typical ECG changes during MI [7,9]. This gender discrep-
ancy in MI trends makes long-term follow-up data even
more interesting, since the results mirror changes in pri-
mary and secondary prevention in the population. Gen-
der discrepancy also gives an indication of health care
quality and whether care is delivered in an equitable man-
ner.
Incidence and mortality due to CHD increase greatly with
age, and thus a rapidly ageing population is a huge chal-
lenge for society. Factors affecting incidence and case
fatality are of utmost importance for CHD mortality.
Hence, time trends in incidence and case fatality in vari-
ous age and gender groups are of profound interest and
can assist public health investigators aiming to decrease
cardiovascular morbidity and mortality. In this aspect,
analysis of time trends based on standardized data-moni-
toring procedures is superior to analyses based on routine
vital statistics. The MONICA centre in Northern Sweden
has continued the MI registration after the WHO project
was ended in 1995. Both first and recurrent MI events are
analysed to understand the effects of primary and second-
ary prevention. Since out-of-hospital deaths are also
included, the register accurately describes the total burden
of the disease. We can now present time trends from 20
years of uniform registration with special emphasis on the
effect of gender on first and recurrent events, case-fatality
and mortality due to MI.
Methods
The WHO MONICA project (Monitoring Trends and
Determinants in Cardiovascular Disease) started in the
beginning of 1980s. Data for MI and for stroke have been
collected from 39 centres in 26 countries [10]. In Sweden
two centres have participated, one in the south (Gothen-
burg area) and Västerbotten and Norrbotten, the two
northernmost counties as one centre. The WHO MONICA
project was ended 1995 but has proceeded as a local
project in northern Sweden. Initially, subjects between 25
and 64 years of age were included. From 2000, patients
aged 65–74 years were also included, but the results for
that age group are not shown due to unreliable trends due
to the short registration period starting 2000. The total
number of MI events in subjects aged 25–64 years during
the 20 years of registration was 11,763.
From 1985 to 2004 all hospital discharge records, general
practitioners reports and death certificates with Interna-
tional Classification of Diseases (ICD) codes were
screened for events. During the 20-year period, 1985–
2004 the ICD classification was changed three times in
Sweden. In the period 1985–86 ICD 8 was used (codes
410–413), from 1987–97 ICD 9 (codes 410–413) and
thereafter ICD 10 (codes I20 – I24). For death certificates
codes were 410–414, 798–799 (ICD 8 and 9) and I20–25,
R96–99 (ICD 10) respectively. Strict WHO MONICA cri-
teria have been used to validate medical history, clinical
symptoms, electrocardiograms (ECG) and cardiac
enzymes, in the same way for fatal as for non-fatal events
as described in detail elsewhere [10-12]. Trained nurses,
supervised by the register physicians, have registered the
MI cases.
ECGs were examined using the Minnesota code. Origi-
nally, MI diagnoses were based on typical chest pain, car-
diac enzymes and ECG findings. From the late 1990s
troponins were introduced for diagnosis of MI, and since
2000 they are the biomarker used by all hospitals in
Northern Sweden.
From 2000, MI diagnosis has been based on typical chest
pain and biomarkers. If only one of these parameters were
positive, ECG analysis was included to get the final diag-
nosis. Based on these parameters, survivors were diag-
nosed as a definite MI or non-MI. Subjects who died
within 28 days from onset of MI were recorded as fatal
cases. This includes prehospital deaths, patients who died
in hospital and patients who were discharged alive, but
died outside hospital within 28 days. An event was con-
sidered to be first ever for the patient if the patient's his-
tory was free from a previous clinically recognized MI,
otherwise the event was considered as recurrent. Total
events describes all events whether or not the patients
have had a previous event. For fatal events both definite
and possible infarctions were included. For this purpose
information was also obtained from death certificates and
necropsy reports when available [10]. In Sweden, official
ischemic heart disease (IHD) mortality statistics are based
on death certificates. Hence all death certificates wereBMC Cardiovascular Disorders 2008, 8:17 http://www.biomedcentral.com/1471-2261/8/17
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screened for acute IHD events. The frequency of necrop-
sies were 56.4% among men and 54.1% among women.
Case fatality is defined as the proportion of fatal events to
all events during the 28 days following the MI.
Statistical analyses
Continuous data are presented as mean and standard
deviation (SD). The target population for men ranged in
the area of 132 000 and 140 000 and for women 126 000
to 131 000 during the 20-year period. Event rates and total
mortality are shown as 3-year rates except for 2003–2004
which was a 2-year interval. Case fatalities are shown as
percentages for the same 3-year and 2-year intervals.
Direct age standardization was used for total events and
mortality. The numbers of cases were divided by the pop-
ulation in each age class and are presented as rates per
100.000 per year in each time interval described. Figures
are age adjusted according to the age distribution of the
total population 2003–2004 in the two northernmost
counties.
Ethical considerations
The Northern Sweden MONICA Study was approved by
the Research Ethics Committee of Umeå University and
the data handling procedures by the National Computer
Data Inspection Board. Participants or relatives to non-
survivors gave written consent.
Results
Table 1 shows baseline characteristics of the subjects in
the study. There were almost 4 times more male subjects
than females. The number of total events in men declined
from 1881 (1985–1987) to 827 (2003–2004). The
decline for women was from 391 (1985–1987) to 248
(2003–2004). The proportion of female subjects with a
first MI in relation to all MI was significantly higher than
for male subjects (73.8 vs 67.0%, p < 0.001). The mean
age at first MI did not change over the period. Women
were approximately 1 year older for both first and recur-
rent MI. Case fatality within 28 days was slightly higher
for men for both first and recurrent MI.
From 1985 to 2000–2002, the total MI events in men aged
25–64 years decreased from 555 to 300/100,000, a 45%
reduction. No further decrease was seen in 2003–2004 as
compared with 2000–2002 (Figure 1). In women total
events were 100/100,000, without any decrease since
1985. This has lead to a reduced risk gap between men
and women from 5.5:1 in the period 1985–87 to 3:1 in
the period 2003–2004.
Data on events in two age groups and according to first or
recurrent MI are given in Figure 2. The changes for men
were pronounced. The reductions in first and recurrent
events were 30% and 70%, respectively in the 55–64 year
age group. For first MI the same trend was seen as in Figure
1 with the major decline occurring between 1985 and
1994–96. In contrast, the declining trend in recurrent MI
continued over the study period. There was no obvious
decline in the events for the youngest age group. For
women, there were no changes in first MI events in any
age group, but women aged 55–64 showed a 40%
decrease in recurrent MI. In the younger group (25–54
years) the event rate was low and no change over time was
noted.
No obvious difference between the sexes in 28-day case
fatality was seen (Figure 3). Over time, case fatality in first
MI declined by almost 50% for both sexes. The reduction
in recurrent MI was around 30% for both sexes, but
remained three times higher than first MI over the study
period. Both sexes showed an almost 50% total reduction
in case fatality in all MI.
Mortality has been reduced since 1985 by 72% for 55–64
year old men but less (50% reduction) for women in the
same age group (Figure 4). For men in the youngest age
groups the decline was 50%, but for women of compara-
ble age the numbers are too small and not conclusive.
Mortality within 28 days for all MI has been reduced by
69% and 45%, in men and women, respectively (Figure
5).
Table 1: Baseline characteristics of the study population.
MI, n (%) Mean age, years (SD) Died within 28 days, n, (%)
MALE First MI 6.292 (67.0) 55.4 (6.9) 1.448 (23.0)
Recurrent MI 3.012 (32.1) 57.2 (6.2) 1.584 (52.6)
Insufficient data 83 (0.9) 57.2 (6.8) 69 (83.1)
All 9.387 56.0 (6.8) 3.101
FEMALE First MI 1.753 (73.8) 56.4 (6.9) 377 (21.5)
Recurrent MI 608 (25.6) 58.1 (6.2) 307 (50.5)
Insufficient data 15 (0.6) 57.1 (6.8) 11 (73.3)
All 2.376 56.8 (6.8) 695
SD = standard deviation, n = numberBMC Cardiovascular Disorders 2008, 8:17 http://www.biomedcentral.com/1471-2261/8/17
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Discussion
The Northern Sweden MONICA study showed declining
trends in MI events and mortality over 20 years, and to our
knowledge, this is the longest population-based study
published relying on standardized data collection proce-
dures. The period 1997–2004 was included in addition to
previous publications and hence data from recent years
are available. Among women the events are declining
mainly for recurrent MI, whereas both first and recurrent
MIs decline among men with the best result for recurrent
MI. Case-fatality trends are similar for both sexes with a
50% improvement from 1985 to 2004. The combination
of lower incidence and higher survival rate translates into
a substantial improvement in mortality, most pro-
nounced in men. Thus, we can extend and confirm previ-
ously published data from Northern Sweden [8].
Comparisons with results from other studies should be
done with caution due to possible methodological differ-
ences. However, other MONICA centres have published
trends in MI events and mortality and, because of the
common MONICA standards used, these studies are more
easily compared. The time span differs, as most trend
studies ended around the mid 1990s. In addition, treat-
ment principles change continuously, thus making a com-
parison with our study not entirely easy.
In the Finnish FINAMI study, incidence of recurrent MI
events was markedly reduced and first MI events were sub-
stantially reduced between 1983 and 1997 among men
and women aged 35–64 years [13]. Similar results were
found for both sexes. This differs considerably from our
results in comparable age groups where the reduction for
a first MI in women was lacking and the reduction for
recurrent MI in women was lower and only found among
those 55–64 years old. For men the reduction in recurrent
MI in our study was similar to the Finnish results, but for
first MI the Swedish reduction was less. The case fatality
trend was markedly better for men in our study and on the
same level for women. Mortality reduction was slightly
better for men and was slightly worse for women in our
study.
The MONICA-Catalonia study 1983 to 1997 [14] showed
an increase in MI events for men but a decreased case
fatality. Case fatality for women was higher than in North-
Age-standardized total event trends in MI for men and women aged 25–64 years Figure 1
Age-standardized total event trends in MI for men and women aged 25–64 years.
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ern Sweden, and no decrease was seen over the time
period. The authors suggest gender disparities in hospital
care as an explanation. Both these results are in contrast to
our data.
Changes in the classic risk factors seem to partly explain
the variation in population trends in CHD [15]. The bur-
den of cardiovascular risk factors in northern Sweden has
changed substantially during the last 20 years as shown in
the population surveys initiated in 1986 as a part of the
MONICA study. At five different time points from 1986 to
2004 randomly chosen inhabitants in the age groups 25–
74 years old (1986 and 1990 only 25–64 years old) were
invited to a population survey where blood pressure, cho-
lesterol level, smoking habits, body mass index (BMI),
waist circumference, diabetes and glucose tolerance, phys-
ical activity and social factors among others were exam-
ined.
Survey data show that smoking has decreased in the pop-
ulation. In fact, the prevalence of male smokers in north-
ern Sweden was lowest among the WHO MONICA
populations at the start and has decreased further since
then. In contrast, the prevalence of female smokers is
higher than for men which is unique in Western Europe
[16,17]. The use of moist oral snuff, "snus", is popular
among men in Sweden. Its use has increased substantially
among men and increased modestly among women. The
possible effect of snuff on CHD has been debated, but
recent studies support many previous ones showing no
increase in the risk of MI [18,19].
Time trends in A) first and B) recurrent MI for men and women in different age groups Figure 2
Time trends in A) first and B) recurrent MI for men and women in different age groups.
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Case-fatality trends for men and women aged 25–64 years Figure 3
Case-fatality trends for men and women aged 25–64 years. A) first MI, B) recurrent MI and C) total events.
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Mortality time trends in MI for A) men and B) women in different age groups Figure 4
Mortality time trends in MI for A) men and B) women in different age groups.
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Total cholesterol levels have decreased considerably dur-
ing the study period but men still exhibit slightly higher
levels than women, and lipid-lowering drugs have con-
tributed only marginally [20]. Blood pressure has
decreased, but only recently, with no major differences
between the sexes [21]. Obesity and overweight are less
prevalent in Sweden than in many other countries and in
the USA. Nevertheless, the proportion of obese people has
doubled and the proportion of overweight men has
increased by about 30%, women by about 20%, since
1980 [22]. Because the increased weight is accompanied
by decreased cholesterol levels, a high caloric intake in
combination with less intake of saturated fats must lie
behind these time trends. In fact, self reported reduced
consumption of saturated fats has also been shown [23].
Physical activity has increased slightly since the first sur-
vey with no difference between the sexes.
Diabetes is a strong risk factor for CHD and is more com-
mon among men than women in northern Sweden. The
decline in incidence and mortality due to coronary artery
disease found in non-diabetics was not seen in diabetics
as shown in a recent publication [24]. This indicates that
diabetics have not benefited from intensified cardiovascu-
lar prevention and treatment to the same degree as
patients without diabetes. However, there were no indica-
tions of any gender difference.
In all, the impact of changes in risk factors on CHD is
complex. Also, during this period of major risk factor
changes, treatment with thrombolytics and secondary pre-
vention with medication such as aspirin, beta blockers
and ACE-inhibitors have been introduced. Invasive treat-
ment with percutaneos coronary interventions and coro-
nary bypass operations have increased significantly. These
changes in coronary care and secondary prevention have
contributed significantly to the decrease in morbidity and
mortality [25].
Risk factors are generally lower in the female population
in Sweden with one important exception. Smoking is
more common among women than men, and it is declin-
ing at a lower pace in women. This may contribute to the
observed result where no decrease in the incidence of first
MI is seen among women. Thus, a thorough analysis on
the handling of risk factors and primary prevention in
women, both in the population at large and through pri-
mary health care, is called for. For men, the positive trend
in first MI correlates fairly well with the decrease in smok-
ing and lower cholesterol levels previously observed in
northern Sweden.
In the present study, recurrent MI in all but the youngest
age groups among women showed an ongoing declining
trend similar to the positive trend for men. Interestingly,
the risk for reinfarction decreased already during the late
Age-standardized mortality (fatal definite + fatal possible) time trends in MI for men and women aged 25–64 years Figure 5
Age-standardized mortality (fatal definite + fatal possible) time trends in MI for men and women aged 25–64 
years.
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1980s for men but not until the mid 1990s for women.
The same trends were seen for total mortality. This indi-
cates a time lag in implementing adequate medical care
and secondary prevention for women. This should be
considered when novel medical treatments are introduced
in order to ascertain equal treatment between the sexes.
The positive trend seen in the last decade shows that car-
diovascular treatment now has been equalized between
the sexes.
Gender differences in the clinical manifestation and pre-
hospital delay of MI have been suggested. Therefore the
Swedish media has asked whether women with MI are
mistreated. However, in northern Sweden we found no
major gender differences in type of symptoms or time
between symptom onset and medical presence as defined
in the WHO MONICA protocol [26].
A limitation of the present study is the introduction of tro-
ponins as markers of myocardial injury, hence markers
not included in the basic MONICA criteria for validation
and classification of events. This means that MI defini-
tions before and after the year of 2000 differs somewhat.
It is however difficult to handle this situation when all
centres in Sweden changed their diagnostic markers and at
the same time stopped using markers decribed in the
WHO MONICA project, and it is also virtually impossible
to include exactly the same definition for MI in all partic-
ipating centres throughout a study period of more than 20
years.
Troponins are more sensitive than previously used
enzyme markers, and hence more patients are diagnosed
as having an MI [27-32]. The introduction of troponins
could explain the result with no further reduction in inci-
dence for men 2003–2004 as compared with 2000–2002.
MI without ST elevation (NSTEMI) has been suggested to
be more frequent for women [7,33-35]. The more fre-
quent NSTEMI in women, together with the higher sensi-
tivity of troponin, may have contributed to the higher
number of MI, hence less reduction in first events and a
lower case fatality for women in the registry since 2000.
Thus the observed effects of troponins may be false nega-
tive with respect to the observed events and the impact of
this more sensitive marker on MI infarctions will be inter-
esting to follow in future analysis.
The validity of our findings is strengthened by the strict
and uniform use of the MONICA criteria over the whole
period. The use of three different ICD classification sys-
tems during the 20-year period should not be a bias since
the codes only have been used to collect possible cases.
For diagnosis the same MONICA definitions have been
used during the period. A major drawback of our registry
is the upper age limit chosen in the WHO MONICA
project since the majority of female MIs occur in older
women. However, future analyses will include at least the
65–74 year age group starting in 2000.
Conclusion
Between 1985 and 2004, the incidence of MI decreased
for men with a substantial decline both in first and recur-
rent MI, whereas the incidence declined mainly for recur-
rent MI among women. This suggests an inferior effect of
primary prevention in women. Case fatality was reduced
by half in both men and women, indicating a similar and
positive effect of acute coronary care. As a result of the
positive effects on incidence and case-fatality, substantial
improvements were also seen in total mortality, most pro-
nounced in men.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
DL participated in the design of the study, performed
parts of the statistical analyses and drafted the manuscript.
LH performed the major part of the statistical analyses. J-
HJ, UN and ME participated in the design of the study and
helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This study was supported by grants from Västerbotten and Norrbotten 
County Councils.
References
1. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski
E, Amouyel P: Contribution of trends in survival and coronary-
event rates to changes in coronary heart disease mortality:
10-year results from 37 WHO MONICA project populations.
Monitoring trends and determinants in cardiovascular dis-
ease.  Lancet 1999, 353:1547-57.
2. Rosen M, Alfredsson L, Hammar N, Kahan T, Spetz CL, Ysberg AS:
Attack rate, mortality and case fatality for acute myocardial
infarction in Sweden during 1987–95. Results from the
national AMI register in Sweden.  J Intern Med 2000, 2:159-64.
3. McGovern PG, Jacobs DR Jr, Shahar E, Arnett DK, Folsom AR, Black-
burn H, Luepker RV: Trends in acute coronary heart disease
mortality, morbidity, and medical care from 1985 through
1997: the Minnesota heart survey.  Circulation 2001, 104:19-24.
4. Abildstrom SZ, Rasmussen S, Rosen M, Madsen M: Trends in inci-
dence and case fatality rates of acute myocardial infarction
in Denmark and Sweden.  Heart 2003, 89:507-11.
5. Myocardial infarctions in Sweden 1987–2002.  The National
Board of Health and Welfare, Centre For Epidemiology; 2005. 
6. Peltonen M, Lundberg V, Huhtasaari F, Asplund K: Marked
improvement in survival after acute myocardial infarction in
middle-aged men but not in women. The Northern Sweden
MONICA study 1985–94.  J Intern Med 2000, 247:579-87.
7. Lundberg V, Wikstrom B, Bostrom S, Asplund K: Exploring sex dif-
ferences in case fatality in acute myocardial infarction or
coronary death events in the northern Sweden MONICA
Project.  J Intern Med 2002, 251:235-44.
8. Messner T, Lundberg V, Bostrom S, Huhtasaari F, Wikstrom B:
Trends in event rates of first and recurrent, fatal and non-
fatal acute myocardial infarction, and 28-day case fatality in
the Northern Sweden MONICA area 1985–98.  Scand J Public
Health 2003, 61:51-9.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cardiovascular Disorders 2008, 8:17 http://www.biomedcentral.com/1471-2261/8/17
Page 10 of 10
(page number not for citation purposes)
9. Lefler L, Bondy K: Women's delay in seeking treatment with
myocardial infarction.  J Cardiovasc Nurs 2004, 19(4):251-68.
10. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas
AM, Pajak A: Myocardial infarction and coronary deaths in the
World Health Organization MONICA Project. Registration
procedures, event rates, and case-fatality rates in 38 popula-
tions from 21 countries in four continents.  Circulation 1994,
90:583-612.
11. Stegmayr B, Lundberg V, Asplund K: The events registration and
survey procedures in the Northern Sweden MONICA
Project.  Scand J Public Health Suppl 2003, 61:9-17.
12. Eriksson M, Stegmayr B, Lundberg V: MONICA quality assess-
ments.  Scand J Public Health Suppl 2003, 61:25-30.
13. Salomaa V, Ketonen M, Koukkunen H, Immonen-Raiha P, Jerkkola T,
Karja-Koskenkari P, Mahonen M, Niemela M, Kuulasmaa K, Palomaki
P, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa
J, Tuomilehto J, Kesaniemi YA, Pyorala K: Trends in coronary
events in Finland during 1983–1997. The FINAMI study.  Eur
Heart J 2003, 24:311-9.
14. Sans S, Puigdefabregas A, Paluzie G, Monterde D, Balaguer-Vintro :
Increasing trends of acute myocardial infarction in Spain: the
MONICA-Catalonia Study.  Eur Heart J 2005, 26:505-15.
15. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolo-
nen H, Evans A, Ferrario M, Tuomilehto J: Estimation of contribu-
tion of changes in classic risk factors to trends in coronary-
event rates across the WHO MONICA Project populations.
Lancet 355(9205):675-87. 2000 Feb 26;
16. Rodu B, Stegmayr B, Nasic S, Asplund K: Impact of smokeless
tobacco use on smoking in northern Sweden.  J Intern Med
2002, 252:398-404.
17. Stegmayr B, Eliasson M, Rodu B: The decline of smoking in north-
ern Sweden.  Scand J Public Health 2005, 33:321-4.
18. Hergens M-P, Ahlbom A, Andersson T, Pershagen G: Swedish
moist snuff and myocardial infarction among men.  Epidemiol-
ogy 2005, 16:12-16.
19. Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson
J-H:  The risk of myocardial infarction and sudden cardiac
death amongst snuff users with or without a previous history
of smoking.  J Intern Med 2007, 262:360-7.
20. Eliasson M, Janlert U, Jansson JH, Stegmayr B: Time trends in pop-
ulation cholesterol levels 1986–2004: influence of lipid-lower-
ing drugs, obesity, smoking and educational level. The
northern Sweden MONICA study.  J Intern Med 2006, 260:551-9.
21. Jansson JH, Boman K, Messner T: Trends in blood pressure, lip-
ids, lipoproteins and glucose metabolism in the Northern
Sweden MONICA project 1986–99.  Scand J Public Health Suppl
2003, 61:43-50.
22. Bostrom G, Eliasson M: Major public health problems – over-
weight and obesity.  Scand J Public Health Suppl 2006, 67:69-77.
23. Krachler B, Eliasson MC, Johansson I, Hallmans G, Lindahl B: Trends
in food intakes in Swedish adults 1986–1999: findings from
the Northern Sweden MONICA (Monitoring of Trends and
Determinants in Cardiovascular Disease) Study.  Public Health
Nutr 2005, 8:628-35.
24. Rautio A, Lundberg V, Messner T, Nasic S, Stegmayr B, Eliasson M:
Favourable trends in the incidence and outcome of myocar-
dial infarction in nondiabetic, but not in diabetic, subjects:
findings from the MONICA myocardial infarction registry in
northern Sweden in 1989–2000.  J Intern Med 2005, 258:369-77.
25. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z,
Kuulasmaa K, Keil U: Estimation of contribution of changes in
coronary care to improving survival, event rates, and coro-
nary heart disease mortality across the WHO MONICA
Project populations.  Lancet 2000, 355:688-700.
26. Isaksson RM, Holmgren L, Lundblad D, Brulin C, Eliasson M: Time
trends in symptoms and prehospital delay time in women vs.
men with myocardial infarction over a 15-year period. The
Northern Sweden MONICA Study.  Eur J Cardiovasc Nurs  in
press. 2007 Oct 31;
27. Koukkunen H, Penttila K, Kemppainen A, Penttila I, Halinen MO, Ran-
tanen T, Pyorala K: Differences in the diagnosis of myocardial
infarction by troponin T compared with clinical and epidemi-
ologic criteria.  Am J Cardiol 2001, 88:727-31.
28. Meier MA, Al-Badr WH, Cooper JV, Kline-Rogers EM, Smith DE,
Eagle KA, Mehta RH: The new definition of myocardial infarc-
tion: diagnostic and prognostic implications in patients with
acute coronary syndromes.  Arch Intern Med 2002, 162:1585-9.
29. Pell JP, Simpson E, Rodger JC, Finlayson A, Clark D, Anderson J, Pell
AC:  Impact of changing diagnostic criteria on incidence,
management, and outcome of acute myocardial infarction:
retrospective cohort study.  BMJ 2003, 326:134-5.
30. Salomaa V, Koukkunen H, Ketonen M, Immonen-Raiha P, Karja-
Koskenkari P, Mustonen J, Lento S, Torppa J, Lehtonen A, Tuomilehto
J, Kesaniemi YA, Pyorala K: A new definition for myocardial inf-
arction: what difference does it make?  Eur Heart J 2005,
26:1719-25.
31. Abildstrom SZ, Rasmussen S, Madsen M: Changes in hospitaliza-
tion rate and mortality after acute myocardial infarction in
Denmark after diagnostic criteria and methods changed.  Eur
Heart J 2005, 26:990-5.
32. Salomaa V, Ketonen M, Koukkunen H, Immonen-Raiha P, Lehtonen A,
Torppa J, Kuulasmaa K, Kesaniemi YA, Pyorala K, FINAMI Study
Group: The effect of correcting for troponins on trends in
coronary heart disease events in Finland during 1993–2002:
the FINAMI study.  Eur Heart J 2006, 27:2394-9.
33. Paul SD, Eagle KA, Guidry U, DiSalvo TG, Villarreal-Levy G, Smith AJ,
O'Donnell CJ, Mahjoub ZA, Muluk V, Newell JB, O'Gara PT: Do gen-
der-based differences in presentation and management
influence predictors of hospitalization costs and length of
stay after an acute myocardial infarction?  Am J Cardiol 1995,
76:1122-5.
34. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G:
Sex differences in myocardial infarction and coronary deaths
in the Scottish MONICA population of Glasgow 1985 to
1991. Presentation, diagnosis, treatment, and 28-day case
fatality of 3991 events in men and 1551 events in women.  Cir-
culation 1996, 93:1981-92.
35. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD,
Werf F Van de, Aylward P, Topol EJ, Califf RM: Sex, clinical pres-
entation, and outcome in patients with acute coronary syn-
dromes. Global use of strategies to open occluded coronary
arteries in acute coronary syndromes IIb Investigators.  N
Engl J Med 1999, 341:226-32.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2261/8/17/prepub